NUGS (Cannabis Strategic Ventures) Current Accrued Expense: $ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannabis Strategic Ventures Current Accrued Expense?

Cannabis Strategic Ventures NUGS +17.33% Current Accrued Expense is $ Mil as of Jun. 2026.

Cannabis Strategic Ventures's Current Accrued Expense for the quarter that ended in Jun. 2026 was $ Mil.

Cannabis Strategic Ventures's quarterly Current Accrued Expense declined from Jun. 2022 ($0.05 Mil) to Jun. 2025 ($ Mil) but then stayed the same from Jun. 2025 ($ Mil) to Jun. 2026 ($ Mil).

Cannabis Strategic Ventures's annual Current Accrued Expense stayed the same from Mar. 2024 ($1.07 Mil) to Mar. 2025 ($1.07 Mil) but then declined from Mar. 2025 ($1.07 Mil) to Mar. 2026 ($0.00 Mil).

Cannabis Strategic Ventures Current Accrued Expense Related Terms

Cannabis Strategic Ventures Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Cannabis Strategic Ventures's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Strategic Ventures Current Accrued Expense Chart

Cannabis Strategic Ventures Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar24 Mar25 Mar26
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 1.07 1.07 1.07 0.00

Cannabis Strategic Ventures Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Jun25 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 1.07 0.05 - -

Cannabis Strategic Ventures Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $ Mil mean?
Cannabis Strategic Ventures (NUGS) has a Current Accrued Expense of $ Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Cannabis Strategic Ventures and its competitors.
Is Cannabis Strategic Ventures' Current Accrued Expense too high?
Cannabis Strategic Ventures' current Current Accrued Expense is $ Mil.
How does Cannabis Strategic Ventures' Current Accrued Expense compare to RDGC and AKRX?
Cannabis Strategic Ventures' Current Accrued Expense of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Cannabis Strategic Ventures and its competitors. Cannabis Strategic Ventures's current Current Accrued Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Strategic Ventures stock overvalued right now?
Cannabis Strategic Ventures (NUGS) has a current Current Accrued Expense of $ Mil. The current Current Accrued Expense is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Cannabis Strategic Ventures (NUGS), the current Current Accrued Expense is $ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Strategic Ventures Business Description

Address 9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212
Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.